A simple index to predict prognosis independent of axillary node information in breast cancer

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 11, 1997, Pages 765-770

  Seshadri, Ram ^a,d   Horsfall, David J ^a   McCaul, Kieran ^b   Leong, Anthony S Y ^c  

^a FLINDERS UNIVERSITY   (Australia)

^b South Australian Health Commission   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Breast cancer prognosis; MIB 1 count

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURVIVAL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INFORMATION; MAJOR CLINICAL STUDY; METASTASIS; MODEL; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TISSUE SECTION;

EID: 0030669097     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb04576.x     Document Type: Article

References (20)

1. Galeu MH, Blamey RW, Elston C, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Can. Res. Trent. 1992; 22: 207-19.
2. Porter-Jordan K, Lippman ME. Overview of the biologic markers of breast cancer. Hematol. Oncol. Clin. North Am. 1994; 8: 73-100.
3. Osborne CK. Prognostic factors for breast cancer: Have they met their promise? Editorial. J. Clin. Oncol. 1992; 10: 679-82.
4. Witzig TE, Ingle JN, Schaid DJ et al. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: Results from patients enrolled in two prospective randomized trials. J. Clin. Oncol. 1993; 11: 351-9.
5. O'Reilly SM, Camplejohn RS, Barnes DM et al. DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br. J. Cancer 1990; 61: 671-4.
6. Cattoretti G, Becker MHG, Key G et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB 3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J. Pathology 1992; 168: 357-63.
7. Seshadri R, Firgaira F, Horsfall DJ, McCaul K, Setlur V, Kitchen P. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. J. Clin. Oncol. 1993; 11: 1936-42.
8. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer. Br. J. Cancer 1957; 11: 359-77.
9. Horsfall DJ, Tilley WD, Orell SR, Marshall VR, Cant ELM. Relationship between ploidy and steroid hormone receptors in primary breast cancer. Br. J. Cancer 1986; 53: 23-8.
10. Seshadri R, Leong A-SY, McCaul K, Firgaira F, Setlur V, Horsfall DJ. Relationship between p53 gene abnormalities and other tumor characteristics in breast cancer prognosis. Int. J. Cancer 1996; 69: 135-41.
11. 1. Gaglia P, Bernardi A, Venesio T, Caldarola B, Lauro D, Cappa AP. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrence. Eur. J. Cancer 1993; 29: 1501-2.
12. Cox DR. Regression models and life-tables. J. R. Stat. Soc. [B] 1972; 34: 187-220.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-81.
14. International (Ludwig) breast cancer study group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990; 335: 1565-8.
15. McGuire WL, Tandon AK, Allred C, Chamness GC, Ravdin PM, Clark GM. Treatment decisions in axillary node-negative breast cancer patients. J. Natl Cancer Inst. Monogr. 1992; 11: 173-80.
16. Bryan RM, Mercer RJ, Bennett RC, Rennie GC. Prognostic factors in breast cancer and the development of a prognostic index. Br. J. Surg. 1986; 73: 267-71.
17. Harvey JM, de-Klerk NH, Sterrett GF. Hislological grading in breast cancer: Interobserver agreement, and relation to other prognostic factors including ploidy. Pathology 1992; 24: 63-8.
18. Rudas M, Gnant MF, Mittlbock M et al. Thymidine labelling index and Ki-67 growth fraction in breast cancer. Breast Cancer Res. Treat. 1994; 32: 165-75.
19. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer 1990; 66: 1663-70.
20. Horsfall DJ, Vella CA, Raymond WA, Leong ASY, Seshadri R. Predicting disease outcome in primary breast cancer using video image analysis. Proc. AACR 1996; 37: 193.